4//SEC Filing
Ampio Pharmaceuticals, Inc. 4
Accession 0001209191-15-063393
CIK 0001411906operating
Filed
Aug 2, 8:00 PM ET
Accepted
Aug 3, 8:12 PM ET
Size
5.7 KB
Accession
0001209191-15-063393
Insider Transaction Report
Form 4
CLIFT VAUGHAN LENNOX
Chief Regulatory Affairs
Transactions
- Award
Stock Option (right to buy)
2015-07-31+170,000→ 170,000 totalExercise: $2.68Exp: 2025-07-31→ Common Stock (170,000 underlying)
Footnotes (1)
- [F1]This is a performance based grant. The grant is issued in connection with an amendment to a certain employment agreement between the Reporting Person and the Issuer. The stock option vests and becomes exercisable upon the successful meeting of all endpoints in the Ampion clinical trial as determined by the Issuer's Compensation Committee of the Board of Directors.
Documents
Issuer
Ampio Pharmaceuticals, Inc.
CIK 0001411906
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001411906
Filing Metadata
- Form type
- 4
- Filed
- Aug 2, 8:00 PM ET
- Accepted
- Aug 3, 8:12 PM ET
- Size
- 5.7 KB